| Новости института: 19.12.2018 Поздравляем!
|
| Поздравляем ученых ФНИСЦ РАН, директора Башкирского филиала, к.соц.н. Р.М. Валиахметова, директора Южнороссийского филиала, д.филос.н. Ю.Г. Волкова, ведущего научного сотрудника, к.филос.н. Ф.Э. Шереги с награждением Почетной грамотой Российской академии наук...
|
| Wearable sweat sensor pioneer issued key device patent
|
| Eccrine Systems, Inc., an advanced sweat sensor company, today announced that a key patent, US10136831, has been issued to Dr. Jason Heikenfeld, Co-Founder & CSO, and prominent University of Cincinnati researcher. The company holds exclusive rights to the UC patent. The patented invention covers the use of on-body sweat devices that are capable of electronically correlating two or more measurements of an analyte with the time at which the analyte emerged in newly excreted sweat.
|
| Criminal history strong indicator for future violent crime
|
 New research shows offenders convicted of a violent crime or other serious felonies will likely commit the same crime again. For example, a prior homicide conviction increased the likelihood by 1,467 percent. Researchers say the findings illustrate the need to consider an offender's entire criminal history during sentencing or when considering parole.
|
| Dive-bombing for love: Male hummingbirds dazzle females with a highly synchronized display
|
 Male Broad-tailed Hummingbirds perform dramatic aerial courtship dives to impress females. In a new study, scientists have shown that diving males closely time key events to produce a burst of signals for the viewer. They synchronize maximal horizontal speed, loud noises generated with their tail feathers, and a display of their iridescent throat-patch (gorget), performed in a mere 300 milliseconds -- roughly the duration of a human blink.
|
|
| Biologists identify promising drug for ALS treatment
|
 A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
|
| Trial may uncover new diagnostics and treatment option for cardiovascular disease
|
 A Wayne State University research team, in collaboration with Arterez, LLC, a Michigan-based biopharmaceutical company, has commenced a clinical study to identify the 'fingerprint' and diagnostic accuracy of Arterez' seven patent-pending glycocalyx biomarkers in relation to arterial disease, specifically hypertension and heart failure. The collaboration aims to help address the rising number of deaths from cardiovascular disease.
|
| Новости института: 14.12.2018 Памяти В.С. Стёпина
|
| 14 декабря 2018 года ушел из жизни заместитель академика-секретаря ООН РАН, почетный директор Института философии РАН, Президент Российского философского общества, лауреат Государственной премии Российской федерации в области науки и технологий, академик РАН Вячеслав Семёнович Стёпин...
|
| Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
|
| An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain. This study combined the results of 96 randomized clinical trials with about 26,000 participants to compare opioids with placebo and nonopioid alternative pain medications for the treatment of chronic noncancer pain.
|
|
, articles in all languages ( English, Russian [ translation ] ) (sources)
